Autolus Therapeutics (AUTL) Leases (2018 - 2025)

Autolus Therapeutics (AUTL) has 8 years of Leases data on file, last reported at $64.9 million in Q4 2025.

• For the quarter ending Q4 2025, Leases rose 17.01% year-over-year to $64.9 million; the trailing twelve-month figure through Dec 2025 stood at $64.9 million (up 17.01% YoY), and the FY2025 full-year result was $64.9 million, up 17.01% from the prior year.
• Leases for Q4 2025 stood at $64.9 million, up from $56.6 million in the prior quarter.
• Across five years, Leases topped out at $64.9 million in Q4 2025 and bottomed at $904000.0 in Q1 2022.
• The 5-year median for Leases is $54.9 million (2023), against an average of $37.7 million.
• The widest annual swing landed in 2022, when Leases plunged 95.74%; it then jumped 2975.45% in 2023.
• A 5-year view of Leases shows it stood at $18.8 million in 2021, then climbed by 23.62% to $23.2 million in 2022, then soared by 161.92% to $60.8 million in 2023, then slipped by 8.71% to $55.5 million in 2024, then gained by 17.01% to $64.9 million in 2025.
• The last three Leases figures came in at $64.9 million (Q4 2025), $56.6 million (Q3 2025), and $58.6 million (Q2 2025), per Business Quant data.

Peer Comparison